DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Cara Therapeutics, Inc. (CARA)
« Back to company indexCARA Chatter Timeline
Stock Ticker for CARA
Most Active Tweeters for CARA
| User | Tweets |
|---|---|
| @Tickeron | 10 |
| @dailypoliticaln | 4 |
| @BlueBioNow | 4 |
| @AmericanBanking | 4 |
| @ZolmaxNews | 4 |
Recent Tweets for CARA
 |
@Tickeron $CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/YfK4gMHsge October 21st 2019, 8:10pm |
 |
@gcassidy718 $CARA Wow. Printing money ???????????????? 2.04 % change recently https://t.co/vZLeec0p8k October 21st 2019, 5:10pm |
 |
@BlueBioNow $CARA Valuation is starting to make more sense now $17.22. https://t.co/mmkUnqqUKF October 21st 2019, 10:10am |
 |
@TranscriptDaily Needham & Company LLC Reaffirms Buy Rating for Cara Therapeutics $CARA https://t.co/CQPKvmwisU October 21st 2019, 6:10am |
 |
@TickerReport Cara Therapeutics Inc $CARA Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/v9gItgjOZs October 21st 2019, 3:10am |
 |
@dailypoliticaln Cara Therapeutics Inc $CARA Given Consensus Recommendation of “Buy” by Analysts https://t.co/la9p3qFQxq October 21st 2019, 3:10am |
|
@Tickeron $CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/fq1aeo4f3a October 20th 2019, 8:10pm |
 |
@ThisLincolnian Cara Therapeutics’ $CARA Buy Rating Reiterated at Needham & Company LLC https://t.co/cBD0yY51pP October 20th 2019, 10:10am |
|
@BlueBioNow $CARA definitely going to finish under $17.22 -2.84 % change recently https://t.co/mmkUnqqUKF October 20th 2019, 8:10am |
|
@Tickeron $CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/5uCOnBk1lM October 19th 2019, 11:10pm |
 |
@dakotafinancial Cara Therapeutics $CARA Given Buy Rating at Needham & Company LLC https://t.co/0yk694ExFC October 19th 2019, 9:10am |
|
@Tickeron $CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/6eOjvSvDC1 October 19th 2019, 1:10am |
 |
@dispatchtribune Cara Therapeutics $CARA Given “Buy” Rating at Needham & Company LLC https://t.co/bL3WAVSfVR October 18th 2019, 5:10pm |
 |
@OlympiaReport Cara Therapeutics $CARA Earns “Buy” Rating from Needham & Company LLC https://t.co/VyhQ7114U7 October 18th 2019, 5:10pm |
 |
@TheMarketsDaily Insider Selling: Cara Therapeutics Inc $CARA SVP Sells 4,000 Shares of Stock https://t.co/Wj2Mof0qYK October 18th 2019, 5:10am |
 |
@macondailynews Frederique Ph.D. Menzaghi Sells 4,000 Shares of Cara Therapeutics Inc $CARA Stock https://t.co/DhTu9ChDsI October 18th 2019, 5:10am |
|
@Tickeron $CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/vlTUpseNVb October 17th 2019, 9:10pm |
 |
@AmericanBanking Cara Therapeutics $CARA Given Buy Rating at Needham & Company LLC https://t.co/iPFqfEmkQ9 #stocks October 17th 2019, 7:10am |
 |
@ConsumerFeed Cara Therapeutics’ $CARA Buy Rating Reaffirmed at Needham & Company LLC https://t.co/bxWdgydbtw October 17th 2019, 7:10am |
 |
@HempNews1 Needham Remains a Buy on Cara Therapeutics (CARA) $CARA #cara https://t.co/SwiyE2mCce October 17th 2019, 7:10am |
 |
@WeekHerald Cara Therapeutics Inc $CARA SVP Frederique Ph.D. Menzaghi Sells 4,000 Shares of Stock https://t.co/0xaV5DRMAd October 17th 2019, 6:10am |
|
@ThisLincolnian Frederique Ph.D. Menzaghi Sells 4,000 Shares of Cara Therapeutics Inc $CARA Stock https://t.co/QfJtNDjH3l October 17th 2019, 6:10am |
|
@Tickeron $CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/S7C6x3qeDO October 16th 2019, 9:10pm |
 |
@ZolmaxNews Cara Therapeutics Inc $CARA SVP Sells $74,800.00 in Stock https://t.co/oVDDzGxsY8 October 16th 2019, 9:10pm |
|
@AmericanBanking Insider Selling: Cara Therapeutics Inc $CARA SVP Sells 4,000 Shares of Stock https://t.co/M1YO1XUzGT #stocks October 16th 2019, 9:10pm |
|
@dailypoliticaln Insider Selling: Cara Therapeutics Inc $CARA SVP Sells 4,000 Shares of Stock https://t.co/0AhRmMkRNQ October 16th 2019, 9:10pm |
 |
@InsiderAlertsIA $CARA: New Insider Filing on Chief Scientific Off,SVP-R&D FREDERIQUE PH.D. MENZAGHI: https://t.co/hn2khyyAKd October 16th 2019, 6:10pm |
 |
@fintel_io Insider Menzaghi Frederique Ph.D. reports selling 4,000 shares of $CARA for a total cost of $74,800.00 [CLICK FOR… https://t.co/VIRPIyxHjS October 16th 2019, 6:10pm |
 |
@confcalltran Chief Scientific Off of Cara Therapeutics just disposed of 4,000 shares https://t.co/NQccNoKy8z $CARA October 16th 2019, 6:10pm |
 |
@WatchlistN Short Interest in Cara Therapeutics Inc $CARA Drops By 5.3% https://t.co/E0eH2k0aip October 16th 2019, 4:10am |
|
@AmericanBanking Short Interest in Cara Therapeutics Inc $CARA Drops By 5.3% https://t.co/W3QkEBpwIJ #stocks October 16th 2019, 4:10am |
|
@Tickeron $CARA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/Pc25go8lJ6 October 15th 2019, 9:10pm |
|
@BlueBioNow $CARA Do we see $21.46 next? 3.45 % change recently https://t.co/mmkUnqqUKF October 15th 2019, 7:10pm |
 |
@sweetbabyfazool $cara data coming in Q4 - then the moon - ez double in 2020 October 15th 2019, 11:10am |
 |
@1MinuteStock We calculated 63-day Expected Return of $CARA for you: -23.25% https://t.co/VVRkDJueNx October 15th 2019, 4:10am |
|
@HempNews1 Cara Delevingne says she's the 'luckiest girl' $CARA #cara https://t.co/eeSxWYzh6R October 15th 2019, 4:10am |
|
@Tickeron $CARA in Uptrend: price expected to rise as it breaks its lower Bollinger Band on September 20, 2019. View odds for… https://t.co/Dz4lK6abfc October 14th 2019, 8:10pm |
 |
@Quantumup1 $CARA kept at a Buy rating , $33 PT at Stifel https://t.co/U3GG0HKTAI October 14th 2019, 11:10am |
 |
@MaisaCorp $CARA an independent data monitoring committee has recommended increasing the enrollment in the phase 3 trial of Ko… https://t.co/JDHQDdtF9e October 14th 2019, 10:10am |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $CARA is $-0.38 it's -2.02% of the current price https://t.co/cktmJAMXcN October 14th 2019, 9:10am |
 |
@AlertTrade RT @Briefingcom: $CARA: Cara Therapeutics reports patient enrollment for KALM-2 Phase 3 Global Trial of KORSUVA increased... https://t.co/b… October 14th 2019, 9:10am |
 |
@Briefingcom $CARA: Cara Therapeutics reports patient enrollment for KALM-2 Phase 3 Global Trial of KORSUVA increased... https://t.co/bnLSVKNSuQ October 14th 2019, 9:10am |
|
@1MinuteStock Wondering about risks of $CARA? The 21-day volatility is 13.75% https://t.co/9TkbXkrCmK October 14th 2019, 9:10am |
|
@biostockinfo RT @BioStocks: $CARA Trial Size to Be Increased to 430 Patients From 350 to Maintain Pre-Specified Statistical Power of 90% or Greater on T… October 14th 2019, 8:10am |
 |
@newswelldone $CARA: Cara to increase enrollment in second late-stage study of Korsuva in …: https://t.co/LYfM5WcO0K October 14th 2019, 8:10am |
 |
@AdmirableAtroc1 RT @MarijuanaStocks: $CARA Announces Completion of Interim Statistical Assessment #potstocks #mjstocks #stocks https://t.co/cBeTwRzyVs October 14th 2019, 8:10am |
 |
@MarijuanaStocks $CARA Announces Completion of Interim Statistical Assessment #potstocks #mjstocks #stocks https://t.co/cBeTwRzyVs October 14th 2019, 8:10am |
 |
@tabuhasna Cara to increase enrollment in second late-stage study of Korsuva in CKD-aP $CARA https://t.co/dITrszjMwx October 14th 2019, 7:10am |
 |
@MarketCurrents $CARA - Cara to increase enrollment in late-stage study of Korsuva in CKD-aP https://t.co/54sl5LAQPG October 14th 2019, 7:10am |
 |
@ToothFrank $CARA Announces Completion of Interim Statistical Assessment and Small Increase in Target Enrollment for KALM-2 Pha… https://t.co/FHYNJtTDbI October 14th 2019, 7:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.